Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

Summary

The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective mutism symptomology.

Timeline

Start

2014-01-01

Primary completion

2015-05-30

Completion

2015-05-30

Drugs

Indications